| Year |
Citation |
Score |
| 2024 |
Ghofrani-Jahromi M, Poudel GR, Razi A, Abeyasinghe PM, Paulsen JS, Tabrizi SJ, Saha S, Georgiou-Karistianis N. Prognostic enrichment for early-stage Huntington's disease: An explainable machine learning approach for clinical trial. Neuroimage. Clinical. 43: 103650. PMID 39142216 DOI: 10.1016/j.nicl.2024.103650 |
0.31 |
|
| 2024 |
Sampaio C, Kostyk SK, Tabrizi SJ, Rosser AE. Refining the Language of Huntington's Disease Progression with the Huntington's Disease Integrated Staging System (HD-ISS). Journal of Huntington's Disease. 13: 115-118. PMID 38968053 DOI: 10.3233/JHD-240043 |
0.309 |
|
| 2024 |
Oosterloo M, Touze A, Byrne LM, Achenbach J, Aksoy H, Coleman A, Lammert D, Nance M, Nopoulos P, Reilmann R, Saft C, Santini H, Squitieri F, Tabrizi S, Burgunder JM, et al. Clinical Review of Juvenile Huntington's Disease. Journal of Huntington's Disease. PMID 38669553 DOI: 10.3233/JHD-231523 |
0.322 |
|
| 2024 |
Knights H, Coleman A, Hobbs NZ, Tabrizi SJ, Scahill RI. Freesurfer Software Update Significantly Impacts Striatal Volumes in the Huntington's Disease Young Adult Study and Will Influence HD-ISS Staging. Journal of Huntington's Disease. PMID 38489194 DOI: 10.3233/JHD-231512 |
0.323 |
|
| 2024 |
Reilmann R, Anderson KE, Feigin A, Tabrizi SJ, Leavitt BR, Stout JC, Piccini P, Schubert R, Loupe P, Wickenberg A, Borowsky B, Rynkowski G, Volkinshtein R, Li T, Savola JM, et al. Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. Neurology. PMID 38280392 DOI: 10.1016/S1474-4422(23)00454-4 |
0.561 |
|
| 2023 |
Liu CF, Younes L, Tong XJ, Hinkle JT, Wang M, Phatak S, Xu X, Bu X, Looi V, Bang J, Tabrizi SJ, Scahill RI, Paulsen JS, Georgiou-Karistianis N, Faria AV, et al. Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease. Brain Communications. 5: fcad214. PMID 37744022 DOI: 10.1093/braincomms/fcad214 |
0.328 |
|
| 2023 |
Estevez-Fraga C, Altmann A, Parker CS, Scahill RI, Costa B, Chen Z, Manzoni C, Zarkali A, Durr A, Roos RAC, Landwehrmeyer B, Leavitt BR, Rees G, Tabrizi SJ, McColgan P. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration. Brain : a Journal of Neurology. PMID 37587097 DOI: 10.1093/brain/awad275 |
0.498 |
|
| 2023 |
Long JD, Gantman EC, Mills JA, Vaidya JG, Mansbach A, Tabrizi SJ, Sampaio C. Applying the Huntington's Disease Integrated Staging System (HD-ISS) to Observational Studies. Journal of Huntington's Disease. PMID 37092230 DOI: 10.3233/JHD-220555 |
0.305 |
|
| 2023 |
Estevez-Fraga C, Elmalem MS, Papoutsi M, Durr A, Rees EM, Hobbs NZ, Roos RAC, Landwehrmeyer B, Leavitt BR, Langbehn DR, Scahill RI, Rees G, Tabrizi SJ, Gregory S. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease. Brain and Behavior. e2940. PMID 36917716 DOI: 10.1002/brb3.2940 |
0.563 |
|
| 2022 |
Papoutsi M, Flower M, Hensman Moss DJ, Holmans P, Estevez-Fraga C, Johnson EB, Scahill RI, Rees G, Langbehn D, Tabrizi SJ. Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington's disease. Brain Communications. 4: fcac279. PMID 36519153 DOI: 10.1093/braincomms/fcac279 |
0.52 |
|
| 2022 |
Estevez-Fraga C, Tabrizi SJ. Disentangling the Connection Between Neurodevelopment and Neurodegeneration in Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36308728 DOI: 10.1002/mds.29267 |
0.342 |
|
| 2022 |
Neueder A, Kojer K, Hering T, Lavery DJ, Chen J, Birth N, Hallitsch J, Trautmann S, Parker J, Flower M, Sethi H, Haider S, Lee JM, Tabrizi SJ, Orth M. Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues. Genome Biology. 23: 189. PMID 36071529 DOI: 10.1186/s13059-022-02752-5 |
0.316 |
|
| 2022 |
McColgan P, Gregory S, Zeun P, Zarkali A, Johnson EB, Parker C, Fayer K, Lowe J, Nair A, Estevez-Fraga C, Papoutsi M, Zhang H, Scahill RI, Tabrizi SJ, Rees G. Neurofilament light associated connectivity in young-adult Huntington's disease is related to neuronal genes. Brain : a Journal of Neurology. PMID 35758263 DOI: 10.1093/brain/awac227 |
0.537 |
|
| 2022 |
Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, Muñoz-Sanjuan I, Sampaio C, Rosser AE, Leavitt BR. Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities. The Lancet. Neurology. 21: 645-658. PMID 35716694 DOI: 10.1016/S1474-4422(22)00121-1 |
0.304 |
|
| 2022 |
Tabrizi SJ, Schobel S, Gantman EC, Mansbach A, Borowsky B, Konstantinova P, Mestre TA, Panagoulias J, Ross CA, Zauderer M, Mullin AP, Romero K, Sivakumaran S, Turner EC, Long JD, et al. A biological classification of Huntington's disease: the Integrated Staging System. The Lancet. Neurology. 21: 632-644. PMID 35716693 DOI: 10.1016/S1474-4422(22)00120-X |
0.331 |
|
| 2022 |
Dewan R, Jaunmuktane Z, Garcia-Segura ME, Strand C, Wild E, Villar J, Dalgard CL, Tabrizi SJ, Traynor BJ, Proukakis C. CAG Somatic Instability in a Huntington Disease Expansion Carrier Presenting with a Progressive Supranuclear Palsy-like Phenotype. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35510647 DOI: 10.1002/mds.29035 |
0.312 |
|
| 2022 |
Zeun P, McColgan P, Dhollander T, Gregory S, Johnson EB, Papoutsi M, Nair A, Scahill RI, Rees G, Tabrizi SJ. Timing of selective basal ganglia white matter loss in premanifest Huntington's disease. Neuroimage. Clinical. 33: 102927. PMID 34999565 DOI: 10.1016/j.nicl.2021.102927 |
0.509 |
|
| 2021 |
Nair A, Niyogi RK, Shang F, Tabrizi SJ, Rees G, Rutledge RB. Opportunity cost determines free-operant action initiation latency and predicts apathy. Psychological Medicine. 53: 1850-1859. PMID 37310334 DOI: 10.1017/S0033291721003469 |
0.389 |
|
| 2021 |
Wijeratne PA, Garbarino S, Gregory S, Johnson EB, Scahill RI, Paulsen JS, Tabrizi SJ, Lorenzi M, Alexander DC. Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease. Neurology. Genetics. 7: e617. PMID 34660889 DOI: 10.1212/NXG.0000000000000617 |
0.367 |
|
| 2021 |
Nair A, Razi A, Gregory S, Rutledge RR, Rees G, Tabrizi SJ. Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington's disease. Brain : a Journal of Neurology. PMID 34633421 DOI: 10.1093/brain/awab367 |
0.508 |
|
| 2021 |
Bunting EL, Hamilton J, Tabrizi SJ. Polyglutamine diseases. Current Opinion in Neurobiology. 72: 39-47. PMID 34488036 DOI: 10.1016/j.conb.2021.07.001 |
0.326 |
|
| 2021 |
Wijeratne PA, Johnson EB, Gregory S, Georgiou-Karistianis N, Paulsen JS, Scahill RI, Tabrizi SJ, Alexander DC. A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington's Disease. Frontiers in Big Data. 4: 662200. PMID 34423286 DOI: 10.3389/fdata.2021.662200 |
0.345 |
|
| 2021 |
McColgan P, Helbling S, Vaculčiaková L, Pine K, Wagstyl K, Attar FM, Edwards L, Papoutsi M, Wei Y, Van den Heuvel MP, Tabrizi SJ, Rees G, Weiskopf N. Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics. Human Brain Mapping. PMID 34272784 DOI: 10.1002/hbm.25595 |
0.456 |
|
| 2021 |
Abeyasinghe PM, Long JD, Razi A, Pustina D, Paulsen JS, Tabrizi SJ, Poudel GR, Georgiou-Karistianis N. Tracking Huntington's Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34014005 DOI: 10.1002/mds.28650 |
0.355 |
|
| 2021 |
O'Regan GC, Farag SH, Casey CS, Wood-Kaczmar A, Pocock JM, Tabrizi SJ, Andre R. Human Huntington's disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species. Journal of Neuroinflammation. 18: 94. PMID 33874957 DOI: 10.1186/s12974-021-02147-6 |
0.302 |
|
| 2021 |
Oosterloo M, de Greef BTA, Bijlsma EK, Durr A, Tabrizi SJ, Estevez-Fraga C, de Die-Smulders CEM, Roos RAC. Disease Onset in Huntington's Disease: When Is the Conversion? Movement Disorders Clinical Practice. 8: 352-360. PMID 33816663 DOI: 10.1002/mdc3.13148 |
0.353 |
|
| 2021 |
Nair A, Johnson EB, Gregory S, Osborne-Crowley K, Zeun P, Scahill RI, Lowe J, Papoutsi M, Palminteri S, Rutledge RB, Rees G, Tabrizi SJ. Aberrant Striatal Value Representation in Huntington's Disease Gene Carriers 25 Years Before Onset. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 33795209 DOI: 10.1016/j.bpsc.2020.12.015 |
0.497 |
|
| 2021 |
Johnson EB, Parker CS, Scahill RI, Gregory S, Papoutsi M, Zeun P, Osborne-Crowley K, Lowe J, Nair A, Estevez-Fraga C, Fayer K, Rees G, Zhang H, Tabrizi SJ. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study. Ebiomedicine. 65: 103266. PMID 33706250 DOI: 10.1016/j.ebiom.2021.103266 |
0.559 |
|
| 2021 |
Estevez-Fraga C, Scahill RI, Durr A, Leavitt BR, Roos RAC, Langbehn DR, Rees G, Gregory S, Tabrizi SJ. Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33471951 DOI: 10.1002/mds.28489 |
0.542 |
|
| 2020 |
Johnson EB, Ziegler G, Penny W, Rees G, Tabrizi SJ, Scahill RI, Gregory S. Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease. Biological Psychiatry. PMID 33500176 DOI: 10.1016/j.biopsych.2020.11.009 |
0.542 |
|
| 2020 |
Rodrigues FB, Byrne LM, Tortelli R, Johnson EB, Wijeratne PA, Arridge M, De Vita E, Ghazaleh N, Houghton R, Furby H, Alexander DC, Tabrizi SJ, Schobel S, Scahill RI, Heslegrave A, et al. Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease. Science Translational Medicine. 12. PMID 33328328 DOI: 10.1126/scitranslmed.abc2888 |
0.353 |
|
| 2020 |
Mitchell CT, Krier I, Arjomand J, Borowsky B, Tabrizi SJ, Leavitt BR, Luthi-Carter R. Longitudinal expression changes are weak correlates of disease progression in Huntington's disease. Brain Communications. 2: fcaa172. PMID 33305259 DOI: 10.1093/braincomms/fcaa172 |
0.403 |
|
| 2020 |
McColgan P, Joubert J, Tabrizi SJ, Rees G. Reply to 'Topographical layer imaging as a tool to track neurodegenerative disease spread in M1'. Nature Reviews. Neuroscience. PMID 33154582 DOI: 10.1038/s41583-020-00405-9 |
0.437 |
|
| 2020 |
Langley C, Gregory S, Osborne-Crowley K, O'Callaghan C, Zeun P, Lowe J, Johnson EB, Papoutsi M, Scahill RI, Rees G, Tabrizi SJ, Robbins TW, Sahakian BJ. Fronto-striatal circuits for cognitive flexibility in far from onset Huntington's disease: evidence from the Young Adult Study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33130575 DOI: 10.1136/jnnp-2020-324104 |
0.507 |
|
| 2020 |
Estevez-Fraga C, Scahill R, Rees G, Tabrizi SJ, Gregory S. Diffusion imaging in Huntington's disease: comprehensive review. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33033167 DOI: 10.1136/jnnp-2020-324377 |
0.594 |
|
| 2020 |
Landles C, Milton RE, Ali N, Flomen R, Flower M, Schindler F, Gomez-Paredes C, Bondulich MK, Osborne GF, Goodwin D, Salsbury G, Benn CL, Sathasivam K, Smith EJ, Tabrizi SJ, et al. Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease Model. Brain Communications. 2: fcaa066. PMID 32954323 DOI: 10.1093/braincomms/fcaa066 |
0.329 |
|
| 2020 |
Papoutsi M, Magerkurth J, Josephs O, Pépés SE, Ibitoye T, Reilmann R, Hunt N, Payne E, Weiskopf N, Langbehn D, Rees G, Tabrizi SJ. Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington's disease. Brain Communications. 2: fcaa049. PMID 32954301 DOI: 10.1093/braincomms/fcaa049 |
0.448 |
|
| 2020 |
McColgan P, Joubert J, Tabrizi SJ, Rees G. The human motor cortex microcircuit: insights for neurodegenerative disease. Nature Reviews. Neuroscience. PMID 32555340 DOI: 10.1038/s41583-020-0315-1 |
0.499 |
|
| 2020 |
Scahill RI, Zeun P, Osborne-Crowley K, Johnson EB, Gregory S, Parker C, Lowe J, Nair A, O'Callaghan C, Langley C, Papoutsi M, McColgan P, Estevez-Fraga C, Fayer K, Wellington H, ... ... Tabrizi SJ, et al. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis. The Lancet. Neurology. 19: 502-512. PMID 32470422 DOI: 10.1016/S1474-4422(20)30143-5 |
0.537 |
|
| 2020 |
Gregory S, Lohse KR, Johnson EB, Leavitt BR, Durr A, Roos RAC, Rees G, Tabrizi SJ, Scahill RI, Orth M. Longitudinal Structural MRI in Neurologically Healthy Adults. Journal of Magnetic Resonance Imaging : Jmri. PMID 32469154 DOI: 10.1002/Jmri.27203 |
0.445 |
|
| 2020 |
Gregory S, Johnson E, Byrne LM, Rodrigues FB, Henderson A, Moss J, Thomas D, Zhang H, De Vita E, Tabrizi SJ, Rees G, Scahill RI, Wild EJ. Characterizing White Matter in Huntington's Disease. Movement Disorders Clinical Practice. 7: 52-60. PMID 31970212 DOI: 10.1002/Mdc3.12866 |
0.569 |
|
| 2019 |
Wild EJ, Tabrizi SJ. One decade ago, one decade ahead in huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 1434-1439. PMID 31769087 DOI: 10.1002/mds.27849 |
0.314 |
|
| 2019 |
Gregory S, Odish OFF, Mayer I, Mills J, Johnson EB, Scahill RI, Rothwell J, Rees G, Long JD, Tabrizi SJ, Roos RAC, Orth M. Multimodal characterization of the visual network in Huntington's disease gene carriers. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 130: 2053-2059. PMID 31541982 DOI: 10.1016/J.Clinph.2019.08.018 |
0.495 |
|
| 2019 |
Ross CA, Reilmann R, Cardoso F, McCusker EA, Testa CM, Stout JC, Leavitt BR, Pei Z, Landwehrmeyer B, Martinez A, Levey J, Srajer T, Bang J, Tabrizi SJ. Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories. Movement Disorders Clinical Practice. 6: 541-546. PMID 31538087 DOI: 10.1002/Mdc3.12808 |
0.469 |
|
| 2019 |
Langbehn DR, Stout JC, Gregory S, Mills JA, Durr A, Leavitt BR, Roos RAC, Long JD, Owen G, Johnson HJ, Borowsky B, Craufurd D, Reilmann R, Landwehrmeyer GB, Scahill RI, ... Tabrizi SJ, et al. Association of CAG Repeats With Long-term Progression in Huntington Disease. Jama Neurology. PMID 31403680 DOI: 10.1001/Jamaneurol.2019.2368 |
0.539 |
|
| 2019 |
Flower M, Lomeikaite V, Ciosi M, Cumming S, Morales F, Lo K, Hensman Moss D, Jones L, Holmans P, Monckton DG, Tabrizi SJ. MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1. Brain : a Journal of Neurology. PMID 31216018 DOI: 10.1093/Brain/Awz115 |
0.33 |
|
| 2019 |
Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease. Neuron. 102: 899. PMID 31121127 DOI: 10.1016/j.neuron.2019.05.001 |
0.331 |
|
| 2019 |
Müller HP, Huppertz HJ, Dreyhaupt J, Ludolph AC, Tabrizi SJ, Roos RAC, Durr A, Landwehrmeyer GB, Kassubek J. Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials. Parkinsonism & Related Disorders. PMID 30846243 DOI: 10.1016/j.parkreldis.2019.02.004 |
0.314 |
|
| 2019 |
Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease. Neuron. 101: 801-819. PMID 30844400 DOI: 10.1016/j.neuron.2019.01.039 |
0.311 |
|
| 2019 |
Zeun P, Scahill RI, Tabrizi SJ, Wild EJ. Fluid and imaging biomarkers for Huntington's disease. Molecular and Cellular Neurosciences. PMID 30807825 DOI: 10.1016/j.mcn.2019.02.004 |
0.352 |
|
| 2019 |
Osborne-Crowley K, Andrews SC, Labuschagne I, Nair A, Scahill R, Craufurd D, Tabrizi SJ, Stout JC. Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-9. PMID 30767839 DOI: 10.1017/S1355617718001224 |
0.538 |
|
| 2019 |
Leavitt B, Tabrizi S, Ducray PS, Wild E, Schlegel V, Hooper G, Nicotra A, Chevure J, Smith A, Lane R, Bennett F, Boak L, Doody R, Schobel S. A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington’s disease Journal of the Neurological Sciences. 405: 26-27. DOI: 10.1016/J.Jns.2019.10.260 |
0.315 |
|
| 2019 |
Tabrizi S. Treating Huntington’s disease Journal of the Neurological Sciences. 405: 3. DOI: 10.1016/J.Jns.2019.10.006 |
0.403 |
|
| 2018 |
Andrews SC, Craufurd D, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Stout JC. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease. Neuropsychology. PMID 30211612 DOI: 10.1037/neu0000479 |
0.542 |
|
| 2018 |
Zhang J, Gregory S, Scahill RI, Durr A, Thomas DL, Lehericy S, Rees G, Tabrizi SJ, Zhang H. In vivo characterization of white matter pathology in pre-manifest Huntington's disease. Annals of Neurology. PMID 30063250 DOI: 10.1002/Ana.25309 |
0.512 |
|
| 2018 |
Baake V, Coppen EM, van Duijn E, Dumas EM, van den Bogaard SJA, Scahill RI, Johnson H, Leavitt B, Durr A, Tabrizi SJ, Craufurd D, Roos RAC. Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study. Neuroimage. Clinical. 19: 66-70. PMID 30035003 DOI: 10.1016/J.Nicl.2018.03.033 |
0.459 |
|
| 2018 |
Lahr J, Minkova L, Tabrizi SJ, Stout JC, Klöppel S, Scheller E. Working Memory-Related Effective Connectivity in Huntington's Disease Patients. Frontiers in Neurology. 9: 370. PMID 29915555 DOI: 10.3389/fneur.2018.00370 |
0.544 |
|
| 2018 |
Gregory S, Scahill RI, Rees G, Tabrizi S. Magnetic Resonance Imaging in Huntington's Disease. Methods in Molecular Biology (Clifton, N.J.). 1780: 303-328. PMID 29856026 DOI: 10.1007/978-1-4939-7825-0_16 |
0.475 |
|
| 2018 |
Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Johnson EB, Durr A, Roos RAC, Leavitt BR, Mills JA, Stout JC, Scahill RI, Tabrizi SJ, Rees G, et al. Testing a longitudinal compensation model in premanifest Huntington's disease. Brain : a Journal of Neurology. PMID 29788038 DOI: 10.1093/Brain/Awy122 |
0.686 |
|
| 2018 |
Wijeratne PA, Young AL, Oxtoby NP, Marinescu RV, Firth NC, Johnson EB, Mohan A, Sampaio C, Scahill RI, Tabrizi SJ, Alexander DC. An image-based model of brain volume biomarker changes in Huntington's disease. Annals of Clinical and Translational Neurology. 5: 570-582. PMID 29761120 DOI: 10.1002/acn3.558 |
0.376 |
|
| 2018 |
Aziz NA, van der Burg JMM, Tabrizi SJ, Landwehrmeyer GB. Overlap between age-at-onset and disease-progression determinants in Huntington disease. Neurology. PMID 29743208 DOI: 10.1212/WNL.0000000000005690 |
0.315 |
|
| 2018 |
Gregory S, Crawford H, Seunarine K, Leavitt B, Durr A, Roos RAC, Scahill RI, Tabrizi SJ, Rees G, Langbehn D, Orth M. Natural biological variation of white matter microstructure is accentuated in Huntington's disease. Human Brain Mapping. PMID 29682858 DOI: 10.1002/Hbm.24191 |
0.559 |
|
| 2018 |
Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease. Neuroimage. Clinical. 17: 312-324. PMID 29527479 DOI: 10.1016/J.Nicl.2017.10.023 |
0.604 |
|
| 2018 |
Ghosh R, Tabrizi SJ. Clinical Features of Huntington's Disease. Advances in Experimental Medicine and Biology. 1049: 1-28. PMID 29427096 DOI: 10.1007/978-3-319-71779-1_1 |
0.327 |
|
| 2018 |
Ghosh R, Tabrizi SJ. Huntington disease. Handbook of Clinical Neurology. 147: 255-278. PMID 29325616 DOI: 10.1016/B978-0-444-63233-3.00017-8 |
0.332 |
|
| 2018 |
Casey CS, Qiu Y, Bentham MP, Smith EJ, Lignani G, Andre R, Wood-Kaczmar A, Tabrizi S. B13 Huntington’s disease phenotypes and disrupted corticostriatal connectivity observed in a novel ipsc-derived in vitro co-culture model Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.65 |
0.323 |
|
| 2017 |
Hensman Moss DJ, Robertson N, Farmer R, Scahill RI, Haider S, Tessari MA, Flynn G, Fischer DF, Wild EJ, Macdonald D, Tabrizi SJ. Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassays. Plos One. 12: e0189891. PMID 29272284 DOI: 10.1371/journal.pone.0189891 |
0.335 |
|
| 2017 |
Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi SJ. Stimulating neural plasticity with real-time fMRI neurofeedback in Huntington's disease: A proof of concept study. Human Brain Mapping. PMID 29239063 DOI: 10.1002/hbm.23921 |
0.489 |
|
| 2017 |
McColgan P, Gregory S, Seunarine KK, Razi A, Papoutsi M, Johnson E, Durr A, Roos RAC, Leavitt BR, Holmans P, Scahill RI, Clark CA, Rees G, Tabrizi SJ. Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes. Biological Psychiatry. PMID 29174593 DOI: 10.1016/J.Biopsych.2017.10.019 |
0.552 |
|
| 2017 |
Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, ... Tabrizi SJ, et al. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology. PMID 29142089 DOI: 10.1212/Wnl.0000000000004743 |
0.306 |
|
| 2017 |
Johnson EB, Gregory S, Johnson HJ, Durr A, Leavitt BR, Roos RA, Rees G, Tabrizi SJ, Scahill RI. Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington's Disease. Frontiers in Neurology. 8: 519. PMID 29066997 DOI: 10.3389/Fneur.2017.00519 |
0.485 |
|
| 2017 |
Hariz M, Tabrizi S. Patients with Huntington's disease pioneered human stereotactic neurosurgery 70 years ago. Brain : a Journal of Neurology. 140: 2516-2519. PMID 29050388 DOI: 10.1093/Brain/Awx193 |
0.374 |
|
| 2017 |
Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis. Jama Neurology. PMID 28975278 DOI: 10.1001/Jamaneurol.2017.2107 |
0.507 |
|
| 2017 |
Scahill RI, Andre R, Tabrizi SJ, Aylward EH. Structural imaging in premanifest and manifest Huntington disease. Handbook of Clinical Neurology. 144: 247-261. PMID 28947121 DOI: 10.1016/B978-0-12-801893-4.00020-1 |
0.348 |
|
| 2017 |
Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C. Design optimization for clinical trials in early-stage manifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906031 DOI: 10.1002/Mds.27122 |
0.528 |
|
| 2017 |
McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. European Journal of Neurology. PMID 28817209 DOI: 10.1111/ene.13413 |
0.369 |
|
| 2017 |
Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S, Holmans P, Jones L, Tabrizi SJ. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. The Lancet. Neurology. PMID 28642124 DOI: 10.1016/S1474-4422(17)30161-8 |
0.42 |
|
| 2017 |
Stuitje G, van Belzen MJ, Gardiner SL, van Roon-Mom WMC, Boogaard MW, Tabrizi SJ, Roos RAC, Aziz NA. Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes. Brain : a Journal of Neurology. PMID 28549075 DOI: 10.1093/brain/awx122 |
0.326 |
|
| 2017 |
Gregory S, Long JD, Tabrizi SJ, Rees G. Measuring compensation in neurodegeneration using MRI. Current Opinion in Neurology. PMID 28537993 DOI: 10.1097/Wco.0000000000000469 |
0.545 |
|
| 2017 |
Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull RLM, Tabrizi SJ, Bates GP. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients. Scientific Reports. 7: 1307. PMID 28465506 DOI: 10.1038/S41598-017-01510-Z |
0.318 |
|
| 2017 |
McColgan P, Seunarine KK, Gregory S, Razi A, Papoutsi M, Long JD, Mills JA, Johnson E, Durr A, Roos RAC, Leavitt BR, Stout JC, Scahill RI, Clark CA, Rees G, ... Tabrizi SJ, et al. Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease. Jci Insight. 2. PMID 28422761 DOI: 10.1172/Jci.Insight.92641 |
0.64 |
|
| 2017 |
Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Papoutsi M, Mills JA, Durr A, Leavitt BR, Roos RA, Stout JC, Scahill RI, Langbehn DR, Tabrizi SJ, et al. Operationalizing compensation over time in neurodegenerative disease. Brain : a Journal of Neurology. PMID 28334888 DOI: 10.1093/Brain/Awx022 |
0.648 |
|
| 2017 |
Hensman Moss DJ, Flower MD, Lo KK, Miller JR, van Ommen GB, 't Hoen PA, Stone TC, Guinee A, Langbehn DR, Jones L, Plagnol V, van Roon-Mom WM, Holmans P, Tabrizi SJ. Huntington's disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer's disease. Scientific Reports. 7: 44849. PMID 28322270 DOI: 10.1038/Srep44849 |
0.339 |
|
| 2017 |
McColgan P, Razi A, Gregory S, Seunarine KK, Durr A, A C Roos R, Leavitt BR, Scahill RI, Clark CA, Langbehn DR, Rees G, Tabrizi SJ. Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease. Human Brain Mapping. PMID 28294457 DOI: 10.1002/Hbm.23527 |
0.465 |
|
| 2017 |
McColgan P, Gregory S, Razi A, Seunarine KK, Gargouri F, Durr A, Roos RA, Leavitt BR, Scahill RI, Clark CA, Tabrizi SJ, Rees G, Coleman A, Decolongon J, et al. White matter predicts functional connectivity in premanifest Huntington's disease. Annals of Clinical and Translational Neurology. 4: 106-118. PMID 28168210 DOI: 10.1002/Acn3.384 |
0.539 |
|
| 2017 |
McColgan P, Seunarine K, Gregory S, Razi A, Papoutsi M, Scahill R, Clark C, Rees G, Tabrizi S. 1609 Length of white matter connexions determine their rate of atrophy in premanifest huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 88: A9.2-A9. DOI: 10.1136/Jnnp-2017-Abn.26 |
0.571 |
|
| 2016 |
Long JD, Langbehn DR, Tabrizi SJ, Landwehrmeyer BG, Paulsen JS, Warner J, Sampaio C. Validation of a prognostic index for Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27892614 DOI: 10.1002/mds.26838 |
0.313 |
|
| 2016 |
Wilson H, Niccolini F, Haider S, Marques TR, Pagano G, Coello C, Natesan S, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M. Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers. Journal of the Neurological Sciences. 368: 243-8. PMID 27538642 DOI: 10.1016/j.jns.2016.07.033 |
0.303 |
|
| 2016 |
Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Klöppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, ... ... Tabrizi SJ, et al. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease. Human Brain Mapping. PMID 27477323 DOI: 10.1002/Hbm.23332 |
0.539 |
|
| 2016 |
Gargouri F, Messé A, Perlbarg V, Valabregue R, McColgan P, Yahia-Cherif L, Fernandez-Vidal S, Ben Hamida A, Benali H, Tabrizi S, Durr A, Lehéricy S. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease. Human Brain Mapping. PMID 27400836 DOI: 10.1002/Hbm.23299 |
0.381 |
|
| 2016 |
Rodrigues FB, Byrne L, McColgan P, Robertson N, Tabrizi SJ, Leavitt BR, Zetterberg H, Wild EJ. Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease. Journal of Neurochemistry. PMID 27344050 DOI: 10.1111/jnc.13719 |
0.31 |
|
| 2016 |
Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O'Regan A, Queller S, Frost C, Leavitt BR, Dürr A, Roos R, Owen G, Borowsky B, Tabrizi SJ, Stout JC, et al. Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-14. PMID 27211109 DOI: 10.1017/S1355617716000321 |
0.577 |
|
| 2016 |
Keogh R, Frost C, Owen G, Daniel RM, Langbehn DR, Leavitt B, Durr A, Roos RA, Landwehrmeyer GB, Reilmann R, Borowsky B, Stout J, Craufurd D, Tabrizi SJ. Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance. Plos Currents. 8. PMID 26819833 DOI: 10.1371/Currents.Hd.8060298Fac1801B01Ccea6Acc00F97Cb |
0.494 |
|
| 2016 |
Moss DH, Pardiñas A, Flower M, Miller J, Lo K, Plagnol V, Holmans P, Jones L, Langbehn D, Tabrizi S. GENETIC MODIFIERS OF HUNTINGTON'S DISEASE PROGRESSION Journal of Neurology, Neurosurgery & Psychiatry. 87: e1.35-e1. DOI: 10.1136/Jnnp-2016-315106.13 |
0.365 |
|
| 2016 |
Bettencourt C, Moss DH, Flower M, Wiethoff S, Giunti P, Durr A, Holmans P, Houlden H, Tabrizi S, Jones L. DNA REPAIR PATHWAYS MODULATE ONSET IN POLYGLUTAMINE DISEASES Journal of Neurology, Neurosurgery & Psychiatry. 87: e1.19-e1. DOI: 10.1136/Jnnp-2016-315106.115 |
0.382 |
|
| 2016 |
Koriath C, Adamson G, Druyeh R, Kenny J, Collinge J, Wild E, Houlden H, Gaskin M, Mead S, Tabrizi S. J9 Probing huntington’s disease phenocopy syndromes with next-generation sequencing Journal of Neurology, Neurosurgery & Psychiatry. 87: A78.2-A78. DOI: 10.1136/Jnnp-2016-314597.221 |
0.343 |
|
| 2016 |
Andrews SC, Craufurd D, Tabrizi S, Stout JC. G1 Executive task performance and anxiety are associated with self-awareness of neuropsychiatric symptoms in huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.152 |
0.512 |
|
| 2016 |
Gargouri F, Messé A, Perlbarg V, Valabregue R, McColgan P, Yahia-Cherif L, Fernandez-Vidal S, Hamida AB, Benali H, Tabrizi S, Durr A, Lehéricy S. D19 Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifest and premanifest huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A41.1-A41. DOI: 10.1136/Jnnp-2016-314597.118 |
0.366 |
|
| 2016 |
McColgan P, Razi A, Seunarine KK, Gregory S, Durr A, Roos RA, Scahill RI, Clark CA, Rees G, Tabrizi SJ. D18 Brain network breakdown and pathophysiological correlates in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A40.2-A40. DOI: 10.1136/Jnnp-2016-314597.117 |
0.479 |
|
| 2015 |
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ. Huntington disease. Nature Reviews. Disease Primers. 1: 15005. PMID 27188817 DOI: 10.1038/nrdp.2015.5 |
0.345 |
|
| 2015 |
Gregory S, Cole JH, Farmer RE, Rees EM, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Zhang H, Scahill RI, Tabrizi SJ, Frost C, Hobbs NZ. Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease. Journal of Huntington's Disease. 4: 333-46. PMID 26756590 DOI: 10.3233/Jhd-150173 |
0.353 |
|
| 2015 |
Minkova L, Scheller E, Peter J, Abdulkadir A, Kaller CP, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling. Frontiers in Human Neuroscience. 9: 634. PMID 26635585 DOI: 10.3389/Fnhum.2015.00634 |
0.334 |
|
| 2015 |
Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RA, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, ... ... Tabrizi SJ, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study. Ebiomedicine. 2: 1420-9. PMID 26629536 DOI: 10.1016/J.Ebiom.2015.08.002 |
0.685 |
|
| 2015 |
Johnson EB, Rees EM, Labuschagne I, Durr A, Leavitt BR, Roos RA, Reilmann R, Johnson H, Hobbs NZ, Langbehn DR, Stout JC, Tabrizi SJ, Scahill RI. The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease. Neuropsychologia. PMID 26519555 DOI: 10.1016/J.Neuropsychologia.2015.10.033 |
0.544 |
|
| 2015 |
Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ. Treating the whole body in Huntington's disease. The Lancet. Neurology. 14: 1135-42. PMID 26466780 DOI: 10.1016/S1474-4422(15)00177-5 |
0.333 |
|
| 2015 |
Andre R, Carty L, Tabrizi SJ. Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis. Current Opinion in Pharmacology. 26: 33-38. PMID 26461267 DOI: 10.1016/j.coph.2015.09.008 |
0.311 |
|
| 2015 |
Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance. Human Brain Mapping. PMID 26453902 DOI: 10.1002/Hbm.23014 |
0.42 |
|
| 2015 |
Gregory S, Scahill RI, Seunarine KK, Stopford C, Zhang H, Zhang J, Orth M, Durr A, Roos RA, Langbehn DR, Long JD, Johnson H, Rees G, Tabrizi SJ, Craufurd D. Neuropsychiatry and White Matter Microstructure in Huntington's Disease. Journal of Huntington's Disease. PMID 26443926 DOI: 10.3233/Jhd-150160 |
0.547 |
|
| 2015 |
McColgan P, Seunarine KK, Razi A, Cole JH, Gregory S, Durr A, Roos RA, Stout JC, Landwehrmeyer B, Scahill RI, Clark CA, Rees G, Tabrizi SJ. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease. Brain : a Journal of Neurology. PMID 26384928 DOI: 10.1093/Brain/Awv259 |
0.676 |
|
| 2015 |
Niccolini F, Haider S, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Piccini P, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M. Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease. Brain : a Journal of Neurology. 138: 3016-29. PMID 26198591 DOI: 10.1093/brain/awv214 |
0.374 |
|
| 2015 |
Sturrock A, Laule C, Wyper K, Milner RA, Decolongon J, Dar Santos R, Coleman AJ, Carter K, Creighton S, Bechtel N, Bohlen S, Reilmann R, Johnson HJ, Hayden MR, Tabrizi SJ, et al. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 393-401. PMID 25690257 DOI: 10.1002/Mds.26118 |
0.353 |
|
| 2015 |
Novak MJ, Seunarine KK, Gibbard CR, McColgan P, Draganski B, Friston K, Clark CA, Tabrizi SJ. Basal ganglia-cortical structural connectivity in Huntington's disease. Human Brain Mapping. 36: 1728-40. PMID 25640796 DOI: 10.1002/Hbm.22733 |
0.387 |
|
| 2015 |
Süssmuth SD, Haider S, Landwehrmeyer GB, Farmer R, Frost C, Tripepi G, Andersen CA, Di Bacco M, Lamanna C, Diodato E, Massai L, Diamanti D, Mori E, Magnoni L, Dreyhaupt J, ... ... Tabrizi SJ, et al. An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease. British Journal of Clinical Pharmacology. 79: 465-76. PMID 25223731 DOI: 10.1111/bcp.12512 |
0.315 |
|
| 2015 |
Ghosh R, Tabrizi SJ. Clinical Aspects of Huntington's Disease. Current Topics in Behavioral Neurosciences. 22: 3-31. PMID 23975844 DOI: 10.1007/7854_2013_238 |
0.339 |
|
| 2015 |
Turner C, Brice A, Bushby K, Riess O, Hanna M, Ommen Gv, Muntoni F, Klockgether T, Wirth B, Lochmüller H, Timmerman V, Schoells L, Straub V, Tabrizi S. NeurOmics: EU-funded-omics research for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.401 |
0.317 |
|
| 2015 |
Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RAC, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, ... ... Tabrizi SJ, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study Ebiomedicine. DOI: 10.1016/j.ebiom.2015.08.002 |
0.655 |
|
| 2014 |
Rees EM, Farmer R, Cole JH, Haider S, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Hobbs NZ. Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1648-54. PMID 25123926 DOI: 10.1002/mds.25984 |
0.344 |
|
| 2014 |
Jones R, Stout JC, Labuschagne I, Say M, Justo D, Coleman A, Dumas EM, Hart E, Owen G, Durr A, Leavitt BR, Roos R, O'Regan A, Langbehn D, Tabrizi SJ, et al. The potential of composite cognitive scores for tracking progression in Huntington's disease. Journal of Huntington's Disease. 3: 197-207. PMID 25062862 DOI: 10.1136/Jnnp-2012-303524.113 |
0.578 |
|
| 2014 |
Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC. The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 673-83. PMID 24757115 DOI: 10.1002/mds.25864 |
0.577 |
|
| 2014 |
Andre R, Scahill RI, Haider S, Tabrizi SJ. Biomarker development for Huntington's disease. Drug Discovery Today. 19: 972-9. PMID 24632006 DOI: 10.1016/j.drudis.2014.03.002 |
0.322 |
|
| 2014 |
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology. 10: 204-16. PMID 24614516 DOI: 10.1038/Nrneurol.2014.24 |
0.567 |
|
| 2014 |
Novak MJ, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, Tabrizi SJ. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 52: 98-112. PMID 24405816 DOI: 10.1016/J.Cortex.2013.11.009 |
0.302 |
|
| 2014 |
Wild E, Robertson N, Miller J, Traeger U, Haider S, Macdonald D, Langbehn D, Kuhn R, Weiss A, Tabrizi S. QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF Journal of Neurology, Neurosurgery & Psychiatry. 85: e4.132-e4. DOI: 10.1136/Jnnp-2014-309236.23 |
0.452 |
|
| 2014 |
Hering T, Kojer K, Birth N, Lenk T, Parker J, Haider S, Tabrizi S, Taanman J, Orth M. D03 Mitochondrial Biogenesis, And Respiratory Chain Assembly And Function, In Skeletal Muscle Of The R6/2 Mouse Model And Human Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A32-A32. DOI: 10.1136/Jnnp-2014-309032.95 |
0.308 |
|
| 2014 |
Hensman D, Wild E, Robertson N, Farmer R, Scahil R, Haider S, Tessari M, Flynn G, Fischer D, Macdonald D, Tabrizi S. D01 Quantification Of Huntingtin Species In Huntington's Disease Patient Leukocytes Using Electrochemiluminescence Immunoassays Journal of Neurology, Neurosurgery & Psychiatry. 85: A31-A32. DOI: 10.1136/Jnnp-2014-309032.93 |
0.437 |
|
| 2014 |
Parker J, Haider S, Miller J, Brown S, Robertson N, Lewis M, Sillery E, Nowak V, Sethi H, Bjorkqvist M, Orth M, Tabrizi S. B37 Investigation Of Viability And Response To Inflammatory Stimuli In Cultured Human Myotubes Derived From Patients With Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A22-A22. DOI: 10.1136/Jnnp-2014-309032.65 |
0.301 |
|
| 2014 |
Reilmann R, Squitieri F, Priller J, Saft C, Mariotti C, Sussmuth S, Nemeth A, Tabrizi S, Quarrell O, Craufurd D, Rickards H, Rosser A, Darpo B, Tessari M, Szynol A, et al. N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial Journal of Neurology, Neurosurgery & Psychiatry. 85: A102-A102. DOI: 10.1136/Jnnp-2014-309032.294 |
0.345 |
|
| 2014 |
Moss DH, Poulter M, Beck J, Polke J, Campbell T, Adamson G, Hehir J, Mudanohwo E, McColgan P, Wild E, Haworth A, Sweeney M, Houlden H, Mead S, Tabrizi S. K11 C9orf72 Expansions Are The Most Common Genetic Cause Of Huntington’s Disease Phenocopy Presentations In A Uk Cohort Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.235 |
0.361 |
|
| 2014 |
Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi S. J02 Brain Training in HD: Enhancing Neural Plasticity using Real-time FMRI Neurofeedback Training Journal of Neurology, Neurosurgery & Psychiatry. 85: A65-A66. DOI: 10.1136/Jnnp-2014-309032.185 |
0.561 |
|
| 2014 |
Petkau T, Russell-Schulz B, Sturrock A, Hutchinson J, Coleman A, Decolongon J, Hayden, Tabrizi S, Mackay A, Leavitt B. E32 A 36 Month Longitudinal Magnetic Resonance Spectroscopy Study In Pre-manifest And Early Huntington Disease Subjects From The Track-hd Study Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.135 |
0.474 |
|
| 2014 |
Haider S, Raftopoulos R, Kapoor R, Tabrizi S. E29 Macular Volume Loss In Huntington’s Disease On Optical Coherence Tomography- A Pilot Biomarker Study Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.132 |
0.384 |
|
| 2014 |
Muller H, Kassubek J, Gron G, Sprengelmeyer R, Hobbs N, Roos R, Duerr A, Tabrizi S, Sussmuth S, Orth M, Landwehrmeyer G. E20 Diffusion Tensor Imaging In Huntington's Disease: Impact Of The Control For Corrupted Data In Comparisons At The Group Level Journal of Neurology, Neurosurgery & Psychiatry. 85: A43-A43. DOI: 10.1136/Jnnp-2014-309032.123 |
0.369 |
|
| 2014 |
Gregory S, Scahill R, Stopford C, Orth M, Durr A, Leavitt B, Roos R, Langbehn D, Johnson H, Rees G, Tabrizi S, Craufurd D. E16 Diffusion Tensor Imaging And Neuropsychiatric Disturbance In Huntington ’s Disease Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.119 |
0.593 |
|
| 2014 |
Gregory S, Scahill R, Durr A, Leavitt B, Roos R, Johnson H, Langbehn, Rees G, Tabrizi S. Structural Connectivity In Huntington'S Disease Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.118 |
0.62 |
|
| 2014 |
McColgan P, Seunarine K, Razi A, Cole J, Scahill R, Rees G, Clark C, Tabrizi S. E12 Abnormal Cortico-striatal Structural Connectivity In Premanifest Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A40-A40. DOI: 10.1136/Jnnp-2014-309032.115 |
0.576 |
|
| 2014 |
Crawford H, Gregory S, Hobbs N, Johnson H, Cole J, Rees E, Malone I, Sprengelmeyer R, Durr A, Leavitt B, Roos R, Langbehn, Landwehrmeyer G, Tabrizi S, Scahill R. Association Between Brain Volume And White Matter Microstructure In Healthy Controls Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.114 |
0.391 |
|
| 2014 |
Johnson E, Rees E, Labuschagne I, Durr A, Leavitt B, Roos R, Johnson H, Hobbs N, Crawford H, Langbehn, Stout J, Tabrizi S, Scahill R. Cortical Thinning Of The Occipital Lobe In Huntington'S Disease And Associations With Cognitive Performance Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.107 |
0.576 |
|
| 2014 |
Pollio G, Massai L, Diamanti D, Magnoni L, Westerberg G, Farmer R, Frost C, Tabrizi S, Landwehrmeyer G, Thomas R. D10 Pharmacodynamic Biomarkers For Selisistat: The Paddington Project Journal of Neurology, Neurosurgery & Psychiatry. 85: A34-A35. DOI: 10.1136/Jnnp-2014-309032.102 |
0.348 |
|
| 2014 |
Tabrizi S. A01 Natural History Of HD In Humans Journal of Neurology, Neurosurgery & Psychiatry. 85: A1-A1. DOI: 10.1136/Jnnp-2014-309032.1 |
0.521 |
|
| 2013 |
Read J, Jones R, Owen G, Leavitt BR, Coleman A, Roos RA, Dumas EM, Durr A, Justo D, Say M, Stout JC, Tabrizi SJ, Craufurd D. Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners. Journal of Huntington's Disease. 2: 159-75. PMID 25063513 DOI: 10.3233/JHD-130051 |
0.532 |
|
| 2013 |
Silajdžić E, Rezeli M, Végvári Ã, Lahiri N, Andre R, Magnusson-Lind A, Nambron R, Kalliolia E, Marko-Varga G, Warner TT, Laurell T, Tabrizi SJ, Björkqvist M. A critical evaluation of inflammatory markers in Huntington's Disease plasma. Journal of Huntington's Disease. 2: 125-34. PMID 25063434 DOI: 10.3233/Jhd-130049 |
0.369 |
|
| 2013 |
Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, Landwehrmeyer B, Reilmann R, Craufurd D, Stout JC, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Scahill RI, et al. Corpus callosal atrophy in premanifest and early Huntington's disease. Journal of Huntington's Disease. 2: 517-26. PMID 25062736 DOI: 10.3233/Jhd-130077 |
0.573 |
|
| 2013 |
Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet. Neurology. 12: 637-49. PMID 23664844 DOI: 10.1016/S1474-4422(13)70088-7 |
0.575 |
|
| 2013 |
Douglas I, Evans S, Rawlins MD, Smeeth L, Tabrizi SJ, Wexler NS. Juvenile Huntington's disease: a population-based study using the General Practice Research Database. Bmj Open. 3. PMID 23558730 DOI: 10.1136/Bmjopen-2012-002085 |
0.303 |
|
| 2013 |
Scheller E, Abdulkadir A, Peter J, Tabrizi SJ, Frackowiak RS, Klöppel S. Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. Neuroimage. 75: 146-54. PMID 23501047 DOI: 10.1016/j.neuroimage.2013.02.058 |
0.341 |
|
| 2013 |
Georgiou-Karistianis N, Scahill R, Tabrizi SJ, Squitieri F, Aylward E. Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. Neuroscience and Biobehavioral Reviews. 37: 480-90. PMID 23376047 DOI: 10.1016/j.neubiorev.2013.01.022 |
0.374 |
|
| 2013 |
Labuschagne I, Jones R, Callaghan J, Whitehead D, Dumas EM, Say MJ, Hart EP, Justo D, Coleman A, Dar Santos RC, Frost C, Craufurd D, Tabrizi SJ, Stout JC. Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease. Psychiatry Research. 207: 118-26. PMID 23051887 DOI: 10.1016/j.psychres.2012.09.022 |
0.433 |
|
| 2013 |
van den Bogaard SJ, Dumas EM, Hart EP, Milles J, Reilmann R, Stout JC, Craufurd D, Gibbard CR, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up. Ajnr. American Journal of Neuroradiology. 34: 317-22. PMID 22918430 DOI: 10.3174/Ajnr.A3303 |
0.591 |
|
| 2013 |
Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, Justo D, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RA, Durr A, Lehéricy S. The structural correlates of functional deficits in early huntington's disease. Human Brain Mapping. 34: 2141-53. PMID 22438242 DOI: 10.1002/Hbm.22055 |
0.538 |
|
| 2013 |
Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, ... ... Tabrizi SJ, et al. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Human Brain Mapping. 34: 519-29. PMID 22102212 DOI: 10.1002/Hbm.21449 |
0.587 |
|
| 2012 |
Dumas EM, Say MJ, Jones R, Labuschagne I, O'Regan AM, Hart EP, van den Bogaard SJ, Queller S, Justo D, Coleman A, Dar Santos RC, Dürr A, Leavitt BR, Tabrizi SJ, Roos RA, et al. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease. Journal of Huntington's Disease. 1: 97-106. PMID 25063192 DOI: 10.3233/JHD-2012-120010 |
0.504 |
|
| 2012 |
Scahill RI, Wild EJ, Tabrizi SJ. Biomarkers for Huntington's disease: an update. Expert Opinion On Medical Diagnostics. 6: 371-5. PMID 23480802 DOI: 10.1517/17530059.2012.701205 |
0.323 |
|
| 2012 |
Stout JC, Jones R, Labuschagne I, O'Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, Dürr A, Leavitt BR, Roos RA, Langbehn DR, ... Tabrizi SJ, et al. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 687-94. PMID 22566599 DOI: 10.1136/jnnp-2011-301940 |
0.518 |
|
| 2012 |
Andre R, Wild EJ, Tabrizi SJ. Huntington's disease: fighting on many fronts. Brain : a Journal of Neurology. 135: 998-1001. PMID 22427330 DOI: 10.1093/brain/aws060 |
0.32 |
|
| 2012 |
Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, Scahill RI, Tabrizi SJ, Ourselin S, Fox NC, Alexander DC. An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. Neuroimage. 60: 1880-9. PMID 22281676 DOI: 10.1016/J.Neuroimage.2012.01.062 |
0.343 |
|
| 2012 |
Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet. Neurology. 11: 42-53. PMID 22137354 DOI: 10.1016/S1474-4422(11)70263-0 |
0.575 |
|
| 2012 |
Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, Hicks SL, Kennard C, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Human Brain Mapping. 33: 203-12. PMID 21264990 DOI: 10.1002/hbm.21205 |
0.548 |
|
| 2012 |
Novak M, Seunarine K, Gibbard C, Clark C, Tabrizi S. G09 Structural connectivity-based topography of the basal ganglia is altered in premanifest and early manifest Huntington's disease Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.89 |
0.469 |
|
| 2012 |
Mueller H, Sprengelmeyer R, Süssmuth S, Groen G, Hobbs N, Roos R, Dürr A, Schoonderbeek A, Hart E', Valabrègue R, Landwehrmeyer GB, Kassubek J, Tabrizi S. A Multicentre Approach For The Detection Of Patterns Of Impairment In Huntington'S Disease By Using Diffusion Tensor Imaging Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.88 |
0.357 |
|
| 2012 |
Cole J, Rees E, Farmer R, Crawford H, Mueller H, Sprengelmeyer R, Frost C, Durr A, Landwehrmeyer B, Tabrizi S, Scahill R, Hobbs N. Reliability Of Diffusion Tensor Imaging Measures Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.87 |
0.363 |
|
| 2012 |
Crawford H, Hobbs N, Cole J, Rees E, Owen G, Langbehn, Frost C, Landwehrmeyer B, Reilmann R, Craufurd D, Stout J, Durr A, Leavitt B, Roos R, Tabrizi S, et al. Corpus Callosal Atrophy In Huntington'S Disease Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.83 |
0.623 |
|
| 2012 |
Hobbs N, Cole J, Farmer R, Rees E, Scahill R, Crawford H, Roos R, Sprengelmeyer R, Durr A, Landwehrmeyer B, Tabrizi S, Frost C. G01 Evaluation of multi-modal, multi-site imaging measures in Huntington's disease: baseline results from the PADDINGTON study Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.81 |
0.452 |
|
| 2012 |
Borowsky B, Warner J, Matson W, Johnson H, Durr A, Roos R, Tabrizi S, Leavitt B, Becker C, Tobin A, Schulman H. F14 8OHdG is not a biomarker for Huntington's disease; lessons for future biomarker studies Journal of Neurology, Neurosurgery & Psychiatry. 83: A25.2-A26. DOI: 10.1136/Jnnp-2012-303524.79 |
0.391 |
|
| 2012 |
Magnusson-Lind A, Davidsson M, Silajdžić E, Hansen C, Tabrizi S, Björkqvist M. B22 Does a peripheral immune response influence muscle pathology in Huntington's disease? Journal of Neurology, Neurosurgery & Psychiatry. 83: A12.2-A12. DOI: 10.1136/Jnnp-2012-303524.38 |
0.323 |
|
| 2012 |
Süssmuth S, Landwehrmeyer G, Tabrizi S, Andersen C, DiBacco M, Tripepi G, Westerberg G. Q02 A randomised, double-blind, placebo-controlled phase IB pharmacodynamic study with selisistat (SEN0014196) in HD patients Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.172 |
0.336 |
|
| 2012 |
Haider S, Andre R, Farmer R, Süssmuth S, Frost C, Bjorkqvist M, Westerberg G, Landwehrmeyer B, Tabrizi S. Sirt 1 Mediated Modulation Of Circulating Cytokines In Huntington'S Disease-Pharmacodynamics Results From Phase 1B Study Of Selisistat-A Sirt 1 Inhibitor Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.171 |
0.356 |
|
| 2012 |
Tabrizi S, investigators TH. A16 Defining predictors of disease Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.16 |
0.496 |
|
| 2012 |
Novak M, Warren J, Henley S, Draganski B, Frackowiak R, Tabrizi S. J13 Distributed neural networks associated with emotion processing are altered in premanifest Huntington's disease and correlated with genetic load Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.123 |
0.349 |
|
| 2012 |
Rees E, Hobbs N, Farmer R, Henley S, Haider S, Scahill R, Tabrizi S. J09 Cognitive functions of the putamen in Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A38.2-A38. DOI: 10.1136/Jnnp-2012-303524.119 |
0.374 |
|
| 2012 |
Wild EJ, Tabrizi SJ. Huntington’s disease Neurogenetics: a Guide For Clinicians. 64-82. DOI: 10.1017/CBO9781139087711.006 |
0.307 |
|
| 2011 |
Novak MJ, Tabrizi SJ. Huntington's disease: clinical presentation and treatment. International Review of Neurobiology. 98: 297-323. PMID 21907093 DOI: 10.1016/B978-0-12-381328-2.00013-4 |
0.372 |
|
| 2011 |
Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, Björkqvist M. Abnormal peripheral chemokine profile in Huntington's disease. Plos Currents. 3: RRN1231. PMID 21826115 DOI: 10.1371/currents.RRN1231 |
0.326 |
|
| 2011 |
Müller HP, Glauche V, Novak MJ, Nguyen-Thanh T, Unrath A, Lahiri N, Read J, Say MJ, Tabrizi SJ, Kassubek J, Kloppel S. Stability of white matter changes related to Huntington's disease in the presence of imaging noise: a DTI study. Plos Currents. 3: RRN1232. PMID 21686312 DOI: 10.1371/Currents.Rrn1232 |
0.364 |
|
| 2011 |
Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, Sturrock A, Craufurd D, Stout JC, Leavitt BR, Barnes J, Tabrizi SJ, Scahill RI. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1684-90. PMID 21557312 DOI: 10.1002/mds.23747 |
0.595 |
|
| 2011 |
Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Human Brain Mapping. 32: 258-70. PMID 21229614 DOI: 10.1002/Hbm.21008 |
0.335 |
|
| 2011 |
Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. The Lancet. Neurology. 10: 83-98. PMID 21163446 DOI: 10.1016/S1474-4422(10)70245-3 |
0.376 |
|
| 2011 |
Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet. Neurology. 10: 31-42. PMID 21130037 DOI: 10.1016/S1474-4422(10)70276-3 |
0.627 |
|
| 2011 |
Say MJ, Jones R, Scahill RI, Dumas EM, Coleman A, Santos RC, Justo D, Campbell JC, Queller S, Shores EA, Tabrizi SJ, Stout JC. Visuomotor integration deficits precede clinical onset in Huntington's disease. Neuropsychologia. 49: 264-70. PMID 21094653 DOI: 10.1016/j.neuropsychologia.2010.11.016 |
0.529 |
|
| 2011 |
van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Early atrophy of pallidum and accumbens nucleus in Huntington's disease. Journal of Neurology. 258: 412-20. PMID 20936300 DOI: 10.1007/S00415-010-5768-0 |
0.323 |
|
| 2010 |
Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, ... ... Tabrizi SJ, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 75: 2150-60. PMID 21068430 DOI: 10.1212/Wnl.0B013E3182020123 |
0.592 |
|
| 2010 |
Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 75: 1702-10. PMID 21060093 DOI: 10.1212/Wnl.0B013E3181Fc27E4 |
0.338 |
|
| 2010 |
Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. Plos Currents. 2: RRN1184. PMID 20890398 DOI: 10.1371/currents.RRN1184 |
0.386 |
|
| 2010 |
Novak MJ, Tabrizi SJ. Huntington's disease. Bmj (Clinical Research Ed.). 340: c3109. PMID 20591965 DOI: 10.1136/bmj.c3109 |
0.321 |
|
| 2010 |
Wild EJ, Henley SM, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 888-95. PMID 20461806 DOI: 10.1002/Mds.22969 |
0.314 |
|
| 2010 |
Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. Ajnr. American Journal of Neuroradiology. 31: 1036-41. PMID 20150305 DOI: 10.3174/Ajnr.A2018 |
0.342 |
|
| 2010 |
Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 756-63. PMID 19955112 DOI: 10.1136/Jnnp.2009.190702 |
0.376 |
|
| 2010 |
Evans K, Vaccarino A, Craufurd D, Callaghan J, Durr A, Leavitt B, Roos R, Tabrizi S. Poster 9: The Short Version of the Problem Behaviours Assessment for HD (PBA-s): An Item Response Analysis Using Data from the TRACK-HD Study Neurotherapeutics. 7: 140-140. DOI: 10.1016/J.Nurt.2009.09.011 |
0.364 |
|
| 2009 |
Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology. 8: 791-801. PMID 19646924 DOI: 10.1016/S1474-4422(09)70170-X |
0.606 |
|
| 2009 |
Klöppel S, Henley SM, Hobbs NZ, Wolf RC, Kassubek J, Tabrizi SJ, Frackowiak RS. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience. 164: 205-19. PMID 19409230 DOI: 10.1016/j.neuroscience.2009.01.045 |
0.334 |
|
| 2009 |
Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, Barker RA, Fox NC, Tabrizi SJ. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. Journal of Neurology. 256: 203-12. PMID 19266143 DOI: 10.1007/S00415-009-0052-X |
0.384 |
|
| 2009 |
Henley SM, Wild EJ, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 932-6. PMID 19243073 DOI: 10.1002/Mds.22485 |
0.335 |
|
| 2009 |
Schippling S, Schneider SA, Bhatia KP, Münchau A, Rothwell JC, Tabrizi SJ, Orth M. Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biological Psychiatry. 65: 959-65. PMID 19200948 DOI: 10.1016/j.biopsych.2008.12.026 |
0.318 |
|
| 2009 |
Klöppel S, Chu C, Tan GC, Draganski B, Johnson H, Paulsen JS, Kienzle W, Tabrizi SJ, Ashburner J, Frackowiak RS. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology. 72: 426-31. PMID 19188573 DOI: 10.1212/01.Wnl.0000341768.28646.B6 |
0.324 |
|
| 2009 |
Rohm S, Bechtel N, Beckmann H, Sturrock A, van den Bogaard S, Say M, Jauffret C, Mills J, Archarya T, Langbehn D, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, ... ... Tabrizi S, et al. Sensitivity of gait analysis to detect motor phenotype in pre-manifest and manifest Huntington's disease – cross-sectional results from the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238520 |
0.574 |
|
| 2009 |
Say M, Bechtel N, Sturrock A, van den Bogaard S, Jauffret C, Bohlen S, Langbehn D, Mills J, Archarya T, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, Tabrizi S, et al. Quantitative motor phenotype assessment in pre-manifest and symptomatic Huntington's disease: tongue force analysis differentiates between disease stages and provides high phenotype correlation. Cross sectional results from the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238518 |
0.442 |
|
| 2009 |
Bechtel N, Jauffret C, Say M, Sturrock A, van den Bogaard S, Mills J, Archarya T, Langbehn D, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, Stout J, Tabrizi S, et al. Finger tapping as an objective motor phenotype marker in pre-manifest and symptomatic Huntington's disease – cross-sectional results from the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238474 |
0.568 |
|
| 2009 |
Novak M, Tan G, Kloeppel S, Ashburner J, Tabrizi S, Frackowiak R. A VBM comparison of cross-sectional and longitudinal grey matter atrophy in premanifest Huntington's disease gene carriers Neuroimage. 47: S92. DOI: 10.1016/S1053-8119(09)70737-2 |
0.385 |
|
| 2009 |
Kloppel S, Chu C, Tan G, Draganski B, Johnson H, Paulsen J, Kienzle W, Tabrizi S, Ashburner J, Frackowiak R. Detecting preclinical neurodegeneration: An example from Huntington's disease Alzheimers & Dementia. 5: 53. DOI: 10.1016/J.Jalz.2009.05.102 |
0.41 |
|
| 2008 |
Wild EJ, Tabrizi SJ. Biomarkers for Huntington's disease. Expert Opinion On Medical Diagnostics. 2: 47-62. PMID 23485116 DOI: 10.1517/17530059.2.1.47 |
0.346 |
|
| 2008 |
Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain : a Journal of Neurology. 131: 2860-9. PMID 18829696 DOI: 10.1093/brain/awn244 |
0.33 |
|
| 2008 |
Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM, Hobbs NZ, Mandelli ML, Grisoli M, Björkhem I, Cattaneo E, Di Donato S. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain : a Journal of Neurology. 131: 2851-9. PMID 18772220 DOI: 10.1093/Brain/Awn212 |
0.335 |
|
| 2008 |
Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C. Oculomotor deficits indicate the progression of Huntington's disease. Progress in Brain Research. 171: 555-8. PMID 18718352 DOI: 10.1016/S0079-6123(08)00678-X |
0.326 |
|
| 2008 |
Klöppel S, Draganski B, Golding CV, Chu C, Nagy Z, Cook PA, Hicks SL, Kennard C, Alexander DC, Parker GJ, Tabrizi SJ, Frackowiak RS. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain : a Journal of Neurology. 131: 196-204. PMID 18056161 DOI: 10.1093/brain/awm275 |
0.346 |
|
| 2007 |
Wild EJ, Petzold A, Keir G, Tabrizi SJ. Plasma neurofilament heavy chain levels in Huntington's disease. Neuroscience Letters. 417: 231-3. PMID 17363167 DOI: 10.1016/j.neulet.2007.02.053 |
0.314 |
|
| 2006 |
Henley SM, Frost C, MacManus DG, Warner TT, Fox NC, Tabrizi SJ. Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology. 67: 694-6. PMID 16924028 DOI: 10.1212/01.Wnl.0000230149.36635.C8 |
0.3 |
|
| 2006 |
Golding CV, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology. 67: 485-7. PMID 16625001 DOI: 10.1212/01.Wnl.0000218215.43328.88 |
0.309 |
|
| 2005 |
Henley SM, Bates GP, Tabrizi SJ. Biomarkers for neurodegenerative diseases. Current Opinion in Neurology. 18: 698-705. PMID 16280682 DOI: 10.1097/01.wco.0000186842.51129.cb |
0.337 |
|
| Show low-probability matches. |